Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Formula: C22H24ClN3O4
InChi: InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23
It may be used alone when other cholesterol-lowering medications are not tolerated
ST2825 significantly decreased bcl-2 expression
Makowski K
Retigabine dihydrochloride Catalog No.:M9949-10 Formula: C22H24ClN3O4Ezogabine, also known as Retigabine, is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. Ezogabine works primarily as a potassium channel openerthat is, by activating a certain family of voltage gated potassium channels in the brain. This mechanism of action is unique among antiepileptic drugs, and may hold promise